Case of pachydermoperiostosis with solute carrier organic anion transporter family, member 2A1 (SLCO2A1) mutations

被引:5
|
作者
Minakawa, Satoko [1 ]
Kaneko, Takahide [1 ]
Niizeki, Hironori [2 ]
Mizukami, Hiroki [3 ]
Saito, Yoko [4 ]
Nigawara, Takeshi [5 ]
Kurose, Rie [6 ]
Nakabayashi, Kazuhiko [7 ]
Kabashima, Kenji [8 ]
Sawamura, Daisuke [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori 0368562, Japan
[2] Natl Ctr Child Hlth & Dev, Dept Dermatol, Tokyo, Japan
[3] Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, Hirosaki, Aomori 0368562, Japan
[4] Hirosaki Univ, Grad Sch Med, Dept Radiol Life Sci, Hirosaki, Aomori 0368562, Japan
[5] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori 0368562, Japan
[6] Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, Hirosaki, Aomori 0368562, Japan
[7] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan
[8] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 606, Japan
来源
JOURNAL OF DERMATOLOGY | 2015年 / 42卷 / 09期
关键词
PRIMARY HYPERTROPHIC OSTEOARTHROPATHY; GENE;
D O I
10.1111/1346-8138.12974
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:908 / 910
页数:3
相关论文
共 50 条
  • [41] Complete type of pachydermoperiostosis with a novel mutation c.510G>A of the SLCO2A1 gene
    Nakazawa, Shinsuke
    Mori, Tatsuyoshi
    Niizeki, Hironori
    Nakabayashi, Kazuhiko
    Tokura, Yoshiki
    JOURNAL OF DERMATOLOGY, 2017, 44 (12): : 1411 - 1412
  • [42] Mutations in the prostaglandin transporter encoding gene SLCO2A1 Cause primary hypertrophic osteoarthropathy and isolated digital clubbing
    Seifert, Wenke
    Kuehnisch, Jirko
    Tueysuez, Beyhan
    Specker, Christof
    Brouwers, Ad
    Horn, Denise
    HUMAN MUTATION, 2012, 33 (04) : 660 - 664
  • [43] Prostaglandin Transporter OATP2A1/SLCO2A1 Is Essential for Body Temperature Regulation during Fever
    Nakamura, Yoshinobu
    Nakanishi, Takeo
    Shimada, Hiroaki
    Shimizu, Junya
    Aotani, Rika
    Maruyama, Shio
    Higuchi, Kei
    Okura, Takashi
    Deguchi, Yoshiharu
    Tamai, Ikumi
    JOURNAL OF NEUROSCIENCE, 2018, 38 (24): : 5584 - 5595
  • [44] Mutations in the SLCO2A1 Gene and Primary Hypertrophic Osteoarthropathy: A Clinical and Biochemical Characterization
    Zhang, Zeng
    He, Jin-Wei
    Fu, Wen-Zhen
    Zhang, Chang-Qing
    Zhang, Zhen-Lin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (05): : E923 - E933
  • [45] Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy
    Xu, Yang
    Zhang, Zeng
    Yue, Hua
    Li, Shanshan
    Zhang, Zhenlin
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (08) : 1459 - 1468
  • [46] Exome Sequencing Identifies SLCO2A1 Mutations as a Cause of Primary Hypertrophic Osteoarthropathy
    Zhang, Zhenlin
    Xia, Weibo
    He, Jinwei
    Zhang, Zeng
    Ke, Yaohua
    Yue, Hua
    Wang, Chun
    Zhang, Hao
    Gu, Jiemei
    Hu, Weiwei
    Fu, Wenzhen
    Hu, Yunqiu
    Li, Miao
    Liu, Yujuan
    AMERICAN JOURNAL OF HUMAN GENETICS, 2012, 90 (01) : 125 - 132
  • [47] Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization
    Zhang, Zeng
    Zhang, Zhen-Lin
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [48] Solute carrier organic anion transporter family member 4A1 promotes colorectal cancer progression and is regulated by miR-1224-5p
    Jiang, Yan
    Zhou, Xizhen
    Li, Yingying
    Gao, Xiaojie
    NEOPLASMA, 2022, 69 (04) : 776 - 784
  • [49] A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy
    Jimbo, Keisuke
    Okuno, Toshiaki
    Ohgaki, Ryuichi
    Nishikubo, Kou
    Kitamura, Yuri
    Sakurai, Yumiko
    Quan, Lili
    Shoji, Hiromichi
    Kanai, Yoshikatsu
    Shimizu, Toshiaki
    Yokomizo, Takehiko
    PLOS ONE, 2020, 15 (11):
  • [50] POTENTIAL OF PROSTAGLANDIN TRANSPORTER OATP2A1/SLCO2A1 AS A TARGET OF NOVEL ANTI-INFLAMMATORY DRUG
    Shimada, Hiroaki
    Nakanishi, Takeo
    Nakamura, Yoshinobu
    Iwaki, Masahiro
    Tamai, Ikumi
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S102 - S103